Brief: Irlab Therapeutics Q1 Operating Loss Widens To SEK 20.0 Mln

IRLAB Therapeutics AB

06/05/2021 06:50

May 6 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB INTERIM REPORT JANUARY - MARCH 2021
    * IRLAB INTERIM REPORT JANUARY - MARCH 2021
    * Q1 OPERATING LOSS SEK 20.0 MILLION VERSUS LOSS SEK 19.1
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkrFLzBn 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))